Association therapeutic

OH+

OH−

Effective

P-value

Bitherapy

15 (31.91%)

39 (11.53%)

54

0.02

Triple therapy

29 (61.70%)

297 (87.86%)

326

0.02

Monotherapy

(Central Antihypertensives)

3 (6.38%)

2 (0.59%)

5

0.02